Calpain interacts with class IA phosphoinositide 3-kinases regulating their stability and signaling activity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 39, 2011, Pages 16217-16222

  Beltran, Luisa ^a   Chaussade, Claire ^a   Vanhaesebroeck, Bart ^a   Cutillas, Pedro Rodriguez ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Lipid signaling; Proteomics; Quantitative analysis

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CALPAIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME PURIFICATION; ENZYME STABILITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; CALPAIN; CHROMATOGRAPHY, AFFINITY; MASS SPECTROMETRY; MICE; NIH 3T3 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 80053650827     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1107692108     Document Type: Article

References (48)

1. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655-1657.
2. Manning BD, Cantley LC (2007) AKT/PKB signaling: Navigating downstream. Cell 129:1261-1274. (Pubitemid 46962095)
3. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 11:329-341.
4. Terauchi Y, et al. (1999) Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat Genet 21:230-235. (Pubitemid 29070374)
5. Randis TM, Puri KD, Zhou H, Diacovo TG (2008) Role of PI3Kδ and PI3Kγ in inflammatory arthritis and tissue localization of neutrophils. Eur J Immunol 38:1215-1224.
6. Ohta H, Arai S, Akita K, Ohta T, Fukuda S (2011) Neurotrophic effects of a cyanine dye via the PI3K-Akt pathway: Attenuation of motor discoordination and neurodegeneration in an ataxic animal model. PLoS One 6:e17137.
7. Samuels Y, Velculescu VE (2004) Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 3:1221-1224. (Pubitemid 40268595)
8. Samuels Y, et al. (2005) Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7:561-573. (Pubitemid 40799249)
9. Myers MP, et al. (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 95:13513-13518. (Pubitemid 28523003)
10. Resjo S, et al. (2002) Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes. Cell Signal 14:231-238. (Pubitemid 34102452)
11. O'Reilly KE, et al. (2006) mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 66:1500-1508. (Pubitemid 43259931)
12. Jones S, Thornton JM (1996) Principles of protein-protein interactions. Proc Natl Acad Sci USA 93:13-20. (Pubitemid 26038096)
13. Uetz P, et al. (2000) A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403:623-627. (Pubitemid 30103994)
14. von Kriegsheim A, et al. (2009) Cell fate decisions are specified by the dynamic ERK interactome. Nat Cell Biol 11:1458-1464.
15. Brazil DP, Park J, Hemmings BA (2002) PKB binding proteins: Getting in on the Akt. Cell 111:293-303. (Pubitemid 35341386)
16. Kim D-H, et al. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110:163-175. (Pubitemid 34876545)
17. Sarbassov DD, et al. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14:1296-1302.
18. Yu J, et al. (1998) Regulation of the p85/p110 phosphatidylinositol 3′-kinase: Stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 18:1379-1387. (Pubitemid 28100902)
19. Geering B, Cutillas PR, Nock G, Gharbi SI, Vanhaesebroeck B (2007) Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Proc Natl Acad Sci USA 104:7809-7814. (Pubitemid 47185833)
20. Kodaki T, Woscholski R, Hallberg B, Rodriguez-Viciana Julian Downward P, Parker PJ (1994) The activation of phosphatidylinositol 3-kinase by Ras. Curr Biol 4:798-806.
21. Gupta S, et al. (2007) Binding of Ras to phosphoinositide 3-kinase p110a is required for Ras-driven Tumorigenesis in mice. Cell 129:957-968. (Pubitemid 46802703)
22. Gupta N, et al. (1999) The SH2 domain-containing inositol 5′-phosphatase (SHIP) recruits the p85 subunit of phosphoinositide 3-kinase during FcgammaRllb1-mediated inhibition of B cell receptor signaling. J Biol Chem 274:7489-7494.
23. Perez OD, et al. (2002) Activation of the PKB/AKT pathway by ICAM-2. Immunity 16:51-65. (Pubitemid 34143216)
24. Vogel LB, Fujita DJ (1993) The SH3 domain of p56lck is involved in binding to phosphatidylinositol 3′-kinase from T lymphocytes. Mol Cell Biol 13:7408-7417.
25. Rabinovsky R, et al. (2009) p85 associates with unphosphorylated PTEN and the PTEN-associated complex. Mol Cell Biol 29:5377-5388.
26. Dengjel J, Kratchmarova I, Blagoev B (2010) Mapping protein-protein interactions by quantitative proteomics. Methods Mol Biol 658:267-278.
27. Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83:731-801. (Pubitemid 36828925)
28. Perrin BJ, Huttenlocher A (2002) Calpain. Int J Biochem Cell Biol 34:722-725. (Pubitemid 34304162)
29. Franco SJ, Huttenlocher A (2005) Regulating cell migration: Calpains make the cut. J Cell Sci 118:3829-3838. (Pubitemid 41410267)
30. Carragher NO, Frame MC (2002) Calpain: A role in cell transformation and migration. Int J Biochem Cell Biol 34:1539-1543.
31. Demarchi F, Schneider C (2007) The Calpain system as a modulator of stress/damage response. Cell Cycle 6:136-138. (Pubitemid 46232490)
32. Dourdin N, et al. (2001) Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J Biol Chem 276:48382-48388.
33. Tan Y, Wu C, De Veyra T, Greer PA (2006) Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J Biol Chem 281:17689-17698. (Pubitemid 44035567)
34. Chaussade C, et al. (2007) Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochem J 404:449-458. (Pubitemid 46953919)
35. Leevers SJ, Vanhaesebroeck B, Waterfield MD (1999) Signalling through phosphoinositide 3-kinases: The lipids take centre stage. Curr Opin Cell Biol 11:219-225. (Pubitemid 29164037)
36. Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606-619. (Pubitemid 44100518)
37. Kok K, Geering B, Vanhaesebroeck B (2009) Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci 34:115-127.
38. Gavin AC, et al. (2006) Proteome survey reveals modularity of the yeast cell machinery. Nature 440:631-636.
39. Guerrero C, Tagwerker C, Kaiser P, Huang L (2006) An integrated mass spectrometry-based proteomic approach: Quantitative analysis of tandem affinity-purified in vivo cross-linked protein complexes (qtax) to decipher the 26 s proteasome-interacting network. Mol Cell Proteomics 5:366-378. (Pubitemid 43329314)
40. Trinkle-Mulcahy L, et al. (2008) Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes. J Cell Biol 183:223-239.
41. Bertoli C, Copetti T, Lam EWF, Demarchi F, Schneider C (2008) Calpain small-1 modulates Akt/FoxO3A signaling and apoptosis through PP2A. Oncogene 28:721-733.
42. Katsube M, et al. (2008) Calpain-mediated regulation of the distinct signaling pathways and cell migration in human neutrophils. J Leukoc Biol 84:255-263. (Pubitemid 351960301)
43. Noma H, et al. (2009) Calpain inhibition induces activation of the distinct signalling pathways and cell migration in human monocytes. Immunology 128:e487-496.
44. Yuan TL, Wulf G, Burga L, Cantley LC (2011) Cell-to-cell variability in PI3K protein level regulates PI3K-AKT pathway activity in cell populations. Curr Biol 21:173-183.
45. Cutillas PR, Geering B, Waterfield MD, Vanhaesebroeck B (2005) Quantification of gel-separated proteins and their phosphorylation sites by LC-MS using unlabeled internal standards: Analysis of phosphoprotein dynamics in a B cell lymphoma cell line. Mol Cell Proteomics 4:1038-1051. (Pubitemid 41223364)
46. Casado P, Cutillas PR (2011) A self-validating quantitative mass spectrometry method for assessing the accuracy of high-content phosphoproteomic experiments. Mol Cell Proteomics 10, 10.1074/mcp.M110.003079.
47. Perkins DN, Pappin DJC, Creasy DM, Cottrell JS (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20:3551-3567. (Pubitemid 30007252)
48. Cutillas PR, Vanhaesebroeck B (2007) Quantitative profile of five murine core proteomes using label-free functional proteomics. Mol Cell Proteomics 6:1560-1573. (Pubitemid 47506167)